Develops drugs that are used to treat rare diseases. Currently has two drugs on the market. In September it formally completed the acquisition of Aegerion Pharmaceuticals Inc.
Full deep dive here:
Definitely on the riskier side of value investing! But like all pharma companies, could fly if a couple of products successfully hit the market!